Total Payments
$5,551
2024 Payments
$585.74
Companies
26
Transactions
132
Medicare Patients
18,247
Medicare Billing
$5.8M
Payment Breakdown by Category
Food & Beverage$5,402 (97.3%)
Other$129.27 (2.3%)
Gifts$19.40 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,402 | 129 | 97.3% |
| Debt forgiveness | $80.77 | 1 | 1.5% |
| Entertainment | $48.50 | 1 | 0.9% |
| Gift | $19.40 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $910.10 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $906.78 | 30 | $0 (2022) |
| Allergan, Inc. | $820.64 | 22 | $0 (2021) |
| Alcon Laboratories Inc | $426.75 | 7 | $0 (2018) |
| Glaukos Corporation | $394.21 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $341.77 | 12 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $248.88 | 3 | $0 (2019) |
| Apellis Pharmaceuticals, Inc. | $245.40 | 4 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $226.72 | 3 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $167.34 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $585.74 | 11 | Alcon Vision LLC ($170.70) |
| 2023 | $289.20 | 8 | Alcon Vision LLC ($112.48) |
| 2022 | $415.80 | 9 | Apellis Pharmaceuticals, Inc. ($208.76) |
| 2021 | $391.86 | 7 | Alcon Vision LLC ($149.43) |
| 2020 | $460.45 | 8 | Alcon Vision LLC ($255.90) |
| 2019 | $1,284 | 27 | Allergan Inc. ($272.66) |
| 2018 | $993.92 | 30 | Novartis Pharmaceuticals Corporation ($303.32) |
| 2017 | $1,130 | 32 | Novartis Pharmaceuticals Corporation ($363.99) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 3 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $124.75 | General |
| Category: Glaucoma | ||||||
| 08/27/2019 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/30/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/13/2019 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $3.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/30/2019 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $124.38 | General |
| Category: OCULAR | ||||||
| 05/21/2019 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: OCULAR | ||||||
| 05/13/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX (Drug) | Food and Beverage | In-kind items and services | $106.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/09/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: OPTHALMICS | ||||||
| 03/31/2019 | Dutch Ophthalmic, USA | EVA Ophthalmic Surgical System (Device) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Ophthalmology | ||||||
| 03/22/2019 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: OCULAR | ||||||
| 03/15/2019 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/12/2019 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $71.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/12/2019 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/01/2019 | Alcon Vision LLC | ReSTOR (Device) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Ophthalmology | ||||||
| 02/26/2019 | Allergan Inc. | ALPHAGAN P (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/31/2019 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug) | Food and Beverage | Cash or cash equivalent | $24.17 | General |
| Category: Ophthalmology | ||||||
| 01/24/2019 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $58.49 | General |
| 01/22/2019 | Alcon Vision LLC | LenSx (Device) | Food and Beverage | In-kind items and services | $142.69 | General |
| Category: Ophthalmology | ||||||
| 01/22/2019 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $45.86 | General |
| Category: Ophthalmology | ||||||
| 01/16/2019 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/28/2018 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/31/2018 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/10/2018 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/08/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $118.87 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 4,235 | 11,169 | $3.4M | $1.3M |
| 2022 | 13 | 4,768 | 12,033 | $3.6M | $1.4M |
| 2021 | 14 | 4,615 | 12,367 | $4.0M | $1.6M |
| 2020 | 13 | 4,629 | 12,331 | $4.3M | $1.6M |
Total Patients
18,247
Total Services
47,900
Medicare Billing
$5.8M
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 77 | 804 | $1.1M | $554,595 | 49.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 402 | 1,781 | $783,011 | $174,518 | 22.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 966 | 1,316 | $368,480 | $135,880 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 422 | 1,757 | $280,821 | $127,212 | 45.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 336 | 1,472 | $161,920 | $107,622 | 66.5% |
| 92250 | Photography of the retina | Office | 2023 | 1,174 | 2,796 | $503,280 | $88,828 | 17.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 244 | 342 | $64,980 | $24,958 | 38.4% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 176 | 189 | $47,250 | $23,500 | 49.7% |
| 92134 | Imaging of retina | Office | 2023 | 303 | 574 | $57,292 | $19,924 | 34.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 51 | 51 | $17,340 | $5,880 | 33.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 66 | 69 | $6,900 | $1,899 | 27.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 18 | 18 | $2,700 | $1,033 | 38.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 70 | 870 | $1.2M | $626,741 | 51.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 419 | 1,829 | $777,920 | $175,653 | 22.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,095 | 1,414 | $391,450 | $142,210 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 430 | 1,786 | $287,261 | $130,449 | 45.4% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 337 | 1,345 | $147,950 | $99,319 | 67.1% |
| 92250 | Photography of the retina | Office | 2022 | 1,202 | 2,795 | $503,100 | $88,097 | 17.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 394 | 602 | $119,511 | $42,970 | 36.0% |
| 92134 | Imaging of retina | Office | 2022 | 571 | 1,068 | $109,165 | $37,270 | 34.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 87 | 94 | $23,500 | $10,849 | 46.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 72 | 72 | $24,360 | $7,460 | 30.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 36 | 101 | $11,110 | $5,266 | 47.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 22 | 22 | $3,300 | $1,155 | 35.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 33 | 35 | $3,500 | $1,093 | 31.2% |
About Dr. Joel Corwin, M.D
Dr. Joel Corwin, M.D is a Ophthalmology healthcare provider based in Ventura, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518901651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joel Corwin, M.D has received a total of $5,551 in payments from pharmaceutical and medical device companies, with $585.74 received in 2024. These payments were reported across 132 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,402).
As a Medicare-enrolled provider, Corwin has provided services to 18,247 Medicare beneficiaries, totaling 47,900 services with total Medicare billing of $5.8M. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Ventura, CA
- Active Since 06/16/2006
- Last Updated 12/16/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1518901651
Products in Payments
- Constellation (Device) $514.04
- LUMIGAN (Drug) $370.99
- ReSTOR (Device) $317.30
- Rhopressa (Drug) $248.88
- EYLEA (Biological) $247.02
- XIIDRA (Drug) $202.22
- RESTASIS (Drug) $177.91
- INVELTYS (Drug) $167.34
- NGENUITY (Device) $149.43
- LenSx (Device) $142.69
- iDose (Device) $136.00
- PAZEO (Drug) $128.46
- iStent inject Trabecular Micro-Bypass Stent System (Device) $127.05
- AcrySof IQ PanOptix (Device) $126.61
- Izervay (Drug) $125.00
- OZURDEX (Drug) $125.00
- BUPARLISIB (Drug) $121.75
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $116.08
- LOTEMAX (Drug) $106.25
- TRAVATAN Z (Drug) $95.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Ventura
John Davidson, M.d, M.D
Ophthalmology — Payments: $368,914
Ophthalmology $368,914
Bryant Lum, M.d, M.D
Ophthalmology — Payments: $108,916
Ophthalmology $108,916
Dr. Aaron Nagiel, M.d., Ph.d, M.D., PH.D
Ophthalmology — Payments: $48,413
Ophthalmology $48,413
Thomas Lee, Md, MD
Ophthalmology — Payments: $12,301
Ophthalmology $12,301
William Trotter, M.d, M.D
Ophthalmology — Payments: $10,713
Ophthalmology $10,713
John Fang, M.d, M.D
Ophthalmology — Payments: $10,643
Ophthalmology $10,643